nodes	percent_of_prediction	percent_of_DWPC	metapath
Suprofen—Ibuprofen—Melphalan—ovarian cancer	0.744	1	CrCrCtD
Suprofen—UGT2B7—Epirubicin—ovarian cancer	0.182	0.852	CbGbCtD
Suprofen—CYP2C9—Paclitaxel—ovarian cancer	0.0317	0.148	CbGbCtD
Suprofen—PTGS2—ovarian follicle—ovarian cancer	0.00629	0.259	CbGeAlD
Suprofen—PTGS1—oviduct—ovarian cancer	0.00289	0.119	CbGeAlD
Suprofen—Tolmetin—CXCL8—ovarian cancer	0.002	0.479	CrCbGaD
Suprofen—UGT2B7—female reproductive system—ovarian cancer	0.00165	0.0681	CbGeAlD
Suprofen—UGT2B7—testis—ovarian cancer	0.00133	0.055	CbGeAlD
Suprofen—Ketoprofen—CXCL8—ovarian cancer	0.000973	0.234	CrCbGaD
Suprofen—Ibuprofen—CXCL8—ovarian cancer	0.000958	0.23	CrCbGaD
Suprofen—PTGS2—myometrium—ovarian cancer	0.000884	0.0364	CbGeAlD
Suprofen—PTGS2—embryo—ovarian cancer	0.000851	0.035	CbGeAlD
Suprofen—PTGS1—epithelium—ovarian cancer	0.000726	0.0299	CbGeAlD
Suprofen—PTGS1—uterine cervix—ovarian cancer	0.00072	0.0296	CbGeAlD
Suprofen—PTGS2—epithelium—ovarian cancer	0.000694	0.0286	CbGeAlD
Suprofen—PTGS2—uterine cervix—ovarian cancer	0.000688	0.0283	CbGeAlD
Suprofen—PTGS1—endometrium—ovarian cancer	0.000651	0.0268	CbGeAlD
Suprofen—PTGS2—endometrium—ovarian cancer	0.000622	0.0256	CbGeAlD
Suprofen—PTGS1—uterus—ovarian cancer	0.0006	0.0247	CbGeAlD
Suprofen—CYP2C9—female reproductive system—ovarian cancer	0.000591	0.0243	CbGeAlD
Suprofen—PTGS2—uterus—ovarian cancer	0.000574	0.0236	CbGeAlD
Suprofen—PTGS1—female reproductive system—ovarian cancer	0.000539	0.0222	CbGeAlD
Suprofen—PTGS2—female reproductive system—ovarian cancer	0.000516	0.0212	CbGeAlD
Suprofen—PTGS1—female gonad—ovarian cancer	0.000491	0.0202	CbGeAlD
Suprofen—PTGS1—vagina—ovarian cancer	0.000488	0.0201	CbGeAlD
Suprofen—PTGS2—bone marrow—ovarian cancer	0.000487	0.02	CbGeAlD
Suprofen—PTGS2—female gonad—ovarian cancer	0.000469	0.0193	CbGeAlD
Suprofen—PTGS2—vagina—ovarian cancer	0.000466	0.0192	CbGeAlD
Suprofen—PTGS1—testis—ovarian cancer	0.000435	0.0179	CbGeAlD
Suprofen—PTGS1—lymph node—ovarian cancer	0.000316	0.013	CbGeAlD
Suprofen—PTGS2—lymph node—ovarian cancer	0.000302	0.0124	CbGeAlD
Suprofen—Ibuprofen—ABCB1—ovarian cancer	0.000238	0.0571	CrCbGaD
Suprofen—PTGS2—Signaling mediated by p38-alpha and p38-beta—ESR1—ovarian cancer	0.000105	0.00759	CbGpPWpGaD
Suprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TOP1—ovarian cancer	9.9e-05	0.00715	CbGpPWpGaD
Suprofen—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	9.82e-05	0.00708	CbGpPWpGaD
Suprofen—PTGS2—S1P1 pathway—VEGFA—ovarian cancer	9.7e-05	0.007	CbGpPWpGaD
Suprofen—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	9.35e-05	0.00675	CbGpPWpGaD
Suprofen—PTGS2—S1P1 pathway—MAPK3—ovarian cancer	9.17e-05	0.00662	CbGpPWpGaD
Suprofen—PTGS1—Selenium Micronutrient Network—SOD1—ovarian cancer	9e-05	0.00649	CbGpPWpGaD
Suprofen—UGT1A1—NRF2 pathway—SLC5A5—ovarian cancer	8.92e-05	0.00644	CbGpPWpGaD
Suprofen—UGT2B7—Biological oxidations—CYP1B1—ovarian cancer	8.92e-05	0.00643	CbGpPWpGaD
Suprofen—UGT1A1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ovarian cancer	8.88e-05	0.00641	CbGpPWpGaD
Suprofen—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—FASN—ovarian cancer	8.88e-05	0.00641	CbGpPWpGaD
Suprofen—UGT2B7—Metapathway biotransformation—CYP1B1—ovarian cancer	8.79e-05	0.00634	CbGpPWpGaD
Suprofen—PTGS2—S1P1 pathway—MAPK1—ovarian cancer	8.73e-05	0.0063	CbGpPWpGaD
Suprofen—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL2—ovarian cancer	8.69e-05	0.00627	CbGpPWpGaD
Suprofen—UGT1A1—NRF2 pathway—SLC2A1—ovarian cancer	8.62e-05	0.00622	CbGpPWpGaD
Suprofen—PTGS2—Aryl Hydrocarbon Receptor—ESR1—ovarian cancer	8.46e-05	0.0061	CbGpPWpGaD
Suprofen—PTGS1—Overview of nanoparticle effects—IL6—ovarian cancer	8.45e-05	0.0061	CbGpPWpGaD
Suprofen—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—SLC2A1—ovarian cancer	8.44e-05	0.00609	CbGpPWpGaD
Suprofen—CYP2C9—Arachidonic acid metabolism—CYP1B1—ovarian cancer	8.34e-05	0.00602	CbGpPWpGaD
Suprofen—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—ovarian cancer	8.14e-05	0.00587	CbGpPWpGaD
Suprofen—PTGS1—Selenium Micronutrient Network—SOD2—ovarian cancer	8.1e-05	0.00584	CbGpPWpGaD
Suprofen—UGT1A1—Biological oxidations—CYP1B1—ovarian cancer	7.24e-05	0.00523	CbGpPWpGaD
Suprofen—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	7.21e-05	0.0052	CbGpPWpGaD
Suprofen—UGT1A1—Metapathway biotransformation—CYP1B1—ovarian cancer	7.15e-05	0.00515	CbGpPWpGaD
Suprofen—PTGS2—Selenium Micronutrient Network—SOD1—ovarian cancer	7.14e-05	0.00515	CbGpPWpGaD
Suprofen—CYP2C9—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	7.12e-05	0.00513	CbGpPWpGaD
Suprofen—PTGS2—Spinal Cord Injury—GADD45A—ovarian cancer	6.96e-05	0.00502	CbGpPWpGaD
Suprofen—PTGS2—Overview of nanoparticle effects—IL6—ovarian cancer	6.71e-05	0.00484	CbGpPWpGaD
Suprofen—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—ovarian cancer	6.65e-05	0.0048	CbGpPWpGaD
Suprofen—PTGS2—Selenium Micronutrient Network—SOD2—ovarian cancer	6.43e-05	0.00464	CbGpPWpGaD
Suprofen—PTGS1—Biological oxidations—CYP1B1—ovarian cancer	5.91e-05	0.00426	CbGpPWpGaD
Suprofen—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	5.84e-05	0.00422	CbGpPWpGaD
Suprofen—PTGS2—Aryl Hydrocarbon Receptor—CDKN1B—ovarian cancer	5.75e-05	0.00415	CbGpPWpGaD
Suprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—ovarian cancer	5.51e-05	0.00397	CbGpPWpGaD
Suprofen—UGT2B7—Metabolism—NME2—ovarian cancer	5.44e-05	0.00392	CbGpPWpGaD
Suprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—ovarian cancer	5.27e-05	0.0038	CbGpPWpGaD
Suprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—ovarian cancer	5.26e-05	0.0038	CbGpPWpGaD
Suprofen—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—ovarian cancer	4.78e-05	0.00345	CbGpPWpGaD
Suprofen—PTGS2—Integrated Pancreatic Cancer Pathway—GADD45A—ovarian cancer	4.73e-05	0.00342	CbGpPWpGaD
Suprofen—PTGS2—Aryl Hydrocarbon Receptor—NRAS—ovarian cancer	4.72e-05	0.00341	CbGpPWpGaD
Suprofen—PTGS1—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	4.55e-05	0.00329	CbGpPWpGaD
Suprofen—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—ovarian cancer	4.49e-05	0.00324	CbGpPWpGaD
Suprofen—UGT1A1—Metabolism—NME2—ovarian cancer	4.42e-05	0.00319	CbGpPWpGaD
Suprofen—PTGS2—Aryl Hydrocarbon Receptor—MYC—ovarian cancer	4.4e-05	0.00317	CbGpPWpGaD
Suprofen—PTGS2—Integrated Pancreatic Cancer Pathway—CHEK2—ovarian cancer	4.33e-05	0.00312	CbGpPWpGaD
Suprofen—PTGS2—Aryl Hydrocarbon Receptor—MAPK1—ovarian cancer	4.3e-05	0.0031	CbGpPWpGaD
Suprofen—PTGS2—Aryl Hydrocarbon Receptor—EGFR—ovarian cancer	4.3e-05	0.0031	CbGpPWpGaD
Suprofen—PTGS2—Spinal Cord Injury—TLR4—ovarian cancer	4.08e-05	0.00295	CbGpPWpGaD
Suprofen—PTGS2—Aryl Hydrocarbon Receptor—KRAS—ovarian cancer	4.06e-05	0.00293	CbGpPWpGaD
Suprofen—PTGS2—Integrated Pancreatic Cancer Pathway—BRCA1—ovarian cancer	4.05e-05	0.00292	CbGpPWpGaD
Suprofen—PTGS2—Disease—HSD17B6—ovarian cancer	3.73e-05	0.00269	CbGpPWpGaD
Suprofen—PTGS2—Integrated Pancreatic Cancer Pathway—BRCA2—ovarian cancer	3.67e-05	0.00264	CbGpPWpGaD
Suprofen—PTGS2—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	3.62e-05	0.00261	CbGpPWpGaD
Suprofen—PTGS1—Metabolism—NME2—ovarian cancer	3.6e-05	0.0026	CbGpPWpGaD
Suprofen—PTGS2—C-MYB transcription factor network—CDKN1B—ovarian cancer	3.55e-05	0.00256	CbGpPWpGaD
Suprofen—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—ovarian cancer	3.55e-05	0.00256	CbGpPWpGaD
Suprofen—PTGS2—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	3.55e-05	0.00256	CbGpPWpGaD
Suprofen—UGT2B7—Metabolism—CYTB—ovarian cancer	3.5e-05	0.00253	CbGpPWpGaD
Suprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TYMS—ovarian cancer	3.49e-05	0.00252	CbGpPWpGaD
Suprofen—PTGS2—Aryl Hydrocarbon Receptor—HRAS—ovarian cancer	3.45e-05	0.00249	CbGpPWpGaD
Suprofen—PTGS2—C-MYB transcription factor network—CCND1—ovarian cancer	3.39e-05	0.00244	CbGpPWpGaD
Suprofen—CYP2C9—Biological oxidations—CYP1B1—ovarian cancer	3.1e-05	0.00224	CbGpPWpGaD
Suprofen—CYP2C9—Metapathway biotransformation—CYP1B1—ovarian cancer	3.06e-05	0.00221	CbGpPWpGaD
Suprofen—UGT2B7—Metabolism—PPP1CC—ovarian cancer	3.06e-05	0.00221	CbGpPWpGaD
Suprofen—UGT2B7—Metabolism—BRIP1—ovarian cancer	3.06e-05	0.00221	CbGpPWpGaD
Suprofen—PTGS1—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	3.05e-05	0.0022	CbGpPWpGaD
Suprofen—PTGS2—Disease—CHMP4C—ovarian cancer	2.98e-05	0.00215	CbGpPWpGaD
Suprofen—PTGS2—C-MYB transcription factor network—NRAS—ovarian cancer	2.92e-05	0.0021	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—NME2—ovarian cancer	2.86e-05	0.00206	CbGpPWpGaD
Suprofen—UGT1A1—Metabolism—CYTB—ovarian cancer	2.85e-05	0.00205	CbGpPWpGaD
Suprofen—PTGS2—Spinal Cord Injury—CXCL8—ovarian cancer	2.77e-05	0.002	CbGpPWpGaD
Suprofen—PTGS2—C-MYB transcription factor network—MYC—ovarian cancer	2.72e-05	0.00196	CbGpPWpGaD
Suprofen—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	2.71e-05	0.00195	CbGpPWpGaD
Suprofen—PTGS2—Spinal Cord Injury—CDKN1B—ovarian cancer	2.71e-05	0.00195	CbGpPWpGaD
Suprofen—PTGS2—Spinal Cord Injury—CASP3—ovarian cancer	2.65e-05	0.00191	CbGpPWpGaD
Suprofen—PTGS2—Spinal Cord Injury—IL2—ovarian cancer	2.65e-05	0.00191	CbGpPWpGaD
Suprofen—PTGS2—Disease—BCL9—ovarian cancer	2.59e-05	0.00187	CbGpPWpGaD
Suprofen—PTGS2—Spinal Cord Injury—CCND1—ovarian cancer	2.58e-05	0.00186	CbGpPWpGaD
Suprofen—PTGS2—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	2.56e-05	0.00185	CbGpPWpGaD
Suprofen—PTGS2—C-MYB transcription factor network—KRAS—ovarian cancer	2.51e-05	0.00181	CbGpPWpGaD
Suprofen—PTGS2—Spinal Cord Injury—MMP9—ovarian cancer	2.51e-05	0.00181	CbGpPWpGaD
Suprofen—PTGS1—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	2.49e-05	0.0018	CbGpPWpGaD
Suprofen—UGT1A1—Metabolism—PPP1CC—ovarian cancer	2.49e-05	0.00179	CbGpPWpGaD
Suprofen—UGT1A1—Metabolism—BRIP1—ovarian cancer	2.49e-05	0.00179	CbGpPWpGaD
Suprofen—PTGS1—Selenium Micronutrient Network—IL6—ovarian cancer	2.48e-05	0.00179	CbGpPWpGaD
Suprofen—PTGS2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	2.42e-05	0.00175	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	2.39e-05	0.00173	CbGpPWpGaD
Suprofen—PTGS1—Metabolism—CYTB—ovarian cancer	2.32e-05	0.00167	CbGpPWpGaD
Suprofen—PTGS1—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	2.27e-05	0.00164	CbGpPWpGaD
Suprofen—PTGS2—C-MYB transcription factor network—HRAS—ovarian cancer	2.13e-05	0.00154	CbGpPWpGaD
Suprofen—PTGS2—Spinal Cord Injury—MAPK3—ovarian cancer	2.13e-05	0.00154	CbGpPWpGaD
Suprofen—PTGS2—Spinal Cord Injury—MYC—ovarian cancer	2.07e-05	0.00149	CbGpPWpGaD
Suprofen—UGT2B7—Metabolism—YAP1—ovarian cancer	2.05e-05	0.00148	CbGpPWpGaD
Suprofen—PTGS1—Metabolism—BRIP1—ovarian cancer	2.03e-05	0.00146	CbGpPWpGaD
Suprofen—PTGS1—Metabolism—PPP1CC—ovarian cancer	2.03e-05	0.00146	CbGpPWpGaD
Suprofen—PTGS2—Spinal Cord Injury—MAPK1—ovarian cancer	2.03e-05	0.00146	CbGpPWpGaD
Suprofen—PTGS2—Spinal Cord Injury—EGFR—ovarian cancer	2.02e-05	0.00146	CbGpPWpGaD
Suprofen—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	1.99e-05	0.00143	CbGpPWpGaD
Suprofen—PTGS2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	1.98e-05	0.00143	CbGpPWpGaD
Suprofen—PTGS2—Selenium Micronutrient Network—IL6—ovarian cancer	1.97e-05	0.00142	CbGpPWpGaD
Suprofen—PTGS2—Disease—PPP1CC—ovarian cancer	1.92e-05	0.00139	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—NME2—ovarian cancer	1.89e-05	0.00137	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—CYTB—ovarian cancer	1.84e-05	0.00133	CbGpPWpGaD
Suprofen—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	1.84e-05	0.00133	CbGpPWpGaD
Suprofen—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	1.8e-05	0.0013	CbGpPWpGaD
Suprofen—PTGS2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.8e-05	0.0013	CbGpPWpGaD
Suprofen—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	1.76e-05	0.00127	CbGpPWpGaD
Suprofen—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	1.74e-05	0.00125	CbGpPWpGaD
Suprofen—PTGS2—Spinal Cord Injury—TP53—ovarian cancer	1.7e-05	0.00123	CbGpPWpGaD
Suprofen—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	1.69e-05	0.00122	CbGpPWpGaD
Suprofen—UGT2B7—Metabolism—FASN—ovarian cancer	1.67e-05	0.00121	CbGpPWpGaD
Suprofen—UGT1A1—Metabolism—YAP1—ovarian cancer	1.67e-05	0.0012	CbGpPWpGaD
Suprofen—UGT2B7—Metabolism—SLC5A5—ovarian cancer	1.65e-05	0.00119	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—BRIP1—ovarian cancer	1.61e-05	0.00116	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—PPP1CC—ovarian cancer	1.61e-05	0.00116	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	1.61e-05	0.00116	CbGpPWpGaD
Suprofen—UGT2B7—Metabolism—SLC2A1—ovarian cancer	1.59e-05	0.00115	CbGpPWpGaD
Suprofen—PTGS2—Spinal Cord Injury—IL6—ovarian cancer	1.56e-05	0.00112	CbGpPWpGaD
Suprofen—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	1.53e-05	0.0011	CbGpPWpGaD
Suprofen—UGT2B7—Metabolism—CYP1B1—ovarian cancer	1.52e-05	0.0011	CbGpPWpGaD
Suprofen—PTGS1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.48e-05	0.00107	CbGpPWpGaD
Suprofen—PTGS2—Disease—HDAC6—ovarian cancer	1.46e-05	0.00105	CbGpPWpGaD
Suprofen—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	1.45e-05	0.00104	CbGpPWpGaD
Suprofen—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	1.41e-05	0.00102	CbGpPWpGaD
Suprofen—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	1.38e-05	0.000994	CbGpPWpGaD
Suprofen—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	1.38e-05	0.000994	CbGpPWpGaD
Suprofen—UGT1A1—Metabolism—FASN—ovarian cancer	1.36e-05	0.000981	CbGpPWpGaD
Suprofen—PTGS1—Metabolism—YAP1—ovarian cancer	1.36e-05	0.000981	CbGpPWpGaD
Suprofen—UGT2B7—Metabolism—PPP2R1A—ovarian cancer	1.35e-05	0.000976	CbGpPWpGaD
Suprofen—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.35e-05	0.000971	CbGpPWpGaD
Suprofen—UGT1A1—Metabolism—SLC5A5—ovarian cancer	1.34e-05	0.000965	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	1.31e-05	0.000944	CbGpPWpGaD
Suprofen—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	1.3e-05	0.000939	CbGpPWpGaD
Suprofen—UGT1A1—Metabolism—SLC2A1—ovarian cancer	1.29e-05	0.000932	CbGpPWpGaD
Suprofen—PTGS2—Disease—XIAP—ovarian cancer	1.26e-05	0.000911	CbGpPWpGaD
Suprofen—UGT2B7—Metabolism—ABCB1—ovarian cancer	1.26e-05	0.000906	CbGpPWpGaD
Suprofen—UGT1A1—Metabolism—CYP1B1—ovarian cancer	1.24e-05	0.000894	CbGpPWpGaD
Suprofen—UGT2B7—Metabolism—TYMS—ovarian cancer	1.23e-05	0.00089	CbGpPWpGaD
Suprofen—PTGS2—Disease—SMARCA4—ovarian cancer	1.23e-05	0.000888	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—CYTB—ovarian cancer	1.22e-05	0.00088	CbGpPWpGaD
Suprofen—PTGS2—Disease—EREG—ovarian cancer	1.2e-05	0.000867	CbGpPWpGaD
Suprofen—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	1.2e-05	0.000862	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.19e-05	0.00086	CbGpPWpGaD
Suprofen—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.18e-05	0.000854	CbGpPWpGaD
Suprofen—PTGS2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.17e-05	0.000846	CbGpPWpGaD
Suprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	1.16e-05	0.000834	CbGpPWpGaD
Suprofen—PTGS1—Metabolism—FASN—ovarian cancer	1.11e-05	0.0008	CbGpPWpGaD
Suprofen—UGT1A1—Metabolism—PPP2R1A—ovarian cancer	1.1e-05	0.000793	CbGpPWpGaD
Suprofen—PTGS1—Metabolism—SLC5A5—ovarian cancer	1.09e-05	0.000787	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—YAP1—ovarian cancer	1.08e-05	0.000779	CbGpPWpGaD
Suprofen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.07e-05	0.000771	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—PPP1CC—ovarian cancer	1.07e-05	0.000769	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—BRIP1—ovarian cancer	1.07e-05	0.000769	CbGpPWpGaD
Suprofen—PTGS1—Metabolism—SLC2A1—ovarian cancer	1.05e-05	0.00076	CbGpPWpGaD
Suprofen—PTGS2—Disease—FASN—ovarian cancer	1.05e-05	0.000758	CbGpPWpGaD
Suprofen—PTGS2—Disease—PARP1—ovarian cancer	1.05e-05	0.000755	CbGpPWpGaD
Suprofen—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.03e-05	0.000744	CbGpPWpGaD
Suprofen—UGT1A1—Metabolism—ABCB1—ovarian cancer	1.02e-05	0.000736	CbGpPWpGaD
Suprofen—PTGS1—Metabolism—CYP1B1—ovarian cancer	1.01e-05	0.000729	CbGpPWpGaD
Suprofen—UGT1A1—Metabolism—TYMS—ovarian cancer	1e-05	0.000723	CbGpPWpGaD
Suprofen—PTGS2—Disease—SLC2A1—ovarian cancer	9.99e-06	0.00072	CbGpPWpGaD
Suprofen—UGT2B7—Metabolism—CAV1—ovarian cancer	9.94e-06	0.000717	CbGpPWpGaD
Suprofen—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	9.77e-06	0.000705	CbGpPWpGaD
Suprofen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	9.39e-06	0.000678	CbGpPWpGaD
Suprofen—UGT2B7—Metabolism—PIK3CG—ovarian cancer	9.05e-06	0.000653	CbGpPWpGaD
Suprofen—PTGS1—Metabolism—PPP2R1A—ovarian cancer	8.96e-06	0.000646	CbGpPWpGaD
Suprofen—PTGS1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	8.91e-06	0.000643	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—FASN—ovarian cancer	8.8e-06	0.000635	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—SLC5A5—ovarian cancer	8.66e-06	0.000625	CbGpPWpGaD
Suprofen—PTGS2—Disease—PPP2R1A—ovarian cancer	8.49e-06	0.000613	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—SLC2A1—ovarian cancer	8.36e-06	0.000603	CbGpPWpGaD
Suprofen—PTGS1—Metabolism—ABCB1—ovarian cancer	8.32e-06	0.0006	CbGpPWpGaD
Suprofen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	8.19e-06	0.000591	CbGpPWpGaD
Suprofen—PTGS1—Metabolism—TYMS—ovarian cancer	8.17e-06	0.000589	CbGpPWpGaD
Suprofen—UGT1A1—Metabolism—CAV1—ovarian cancer	8.07e-06	0.000583	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—CYP1B1—ovarian cancer	8.02e-06	0.000578	CbGpPWpGaD
Suprofen—UGT2B7—Metabolism—PIK3CD—ovarian cancer	7.96e-06	0.000574	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	7.77e-06	0.000561	CbGpPWpGaD
Suprofen—UGT1A1—Metabolism—PIK3CG—ovarian cancer	7.35e-06	0.000531	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—YAP1—ovarian cancer	7.15e-06	0.000516	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—PPP2R1A—ovarian cancer	7.11e-06	0.000513	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	7.08e-06	0.000511	CbGpPWpGaD
Suprofen—PTGS2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	7.08e-06	0.000511	CbGpPWpGaD
Suprofen—UGT2B7—Metabolism—PIK3CB—ovarian cancer	6.93e-06	0.0005	CbGpPWpGaD
Suprofen—PTGS2—Disease—TERT—ovarian cancer	6.75e-06	0.000487	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—ABCB1—ovarian cancer	6.6e-06	0.000476	CbGpPWpGaD
Suprofen—PTGS1—Metabolism—CAV1—ovarian cancer	6.58e-06	0.000475	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—TYMS—ovarian cancer	6.48e-06	0.000468	CbGpPWpGaD
Suprofen—UGT1A1—Metabolism—PIK3CD—ovarian cancer	6.47e-06	0.000466	CbGpPWpGaD
Suprofen—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	6.29e-06	0.000454	CbGpPWpGaD
Suprofen—PTGS2—Disease—CAV1—ovarian cancer	6.24e-06	0.00045	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	6.22e-06	0.000449	CbGpPWpGaD
Suprofen—PTGS1—Metabolism—PIK3CG—ovarian cancer	6e-06	0.000433	CbGpPWpGaD
Suprofen—UGT2B7—Metabolism—PTEN—ovarian cancer	5.99e-06	0.000432	CbGpPWpGaD
Suprofen—PTGS2—Disease—IL6ST—ovarian cancer	5.91e-06	0.000427	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—FASN—ovarian cancer	5.83e-06	0.000421	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—SLC5A5—ovarian cancer	5.73e-06	0.000414	CbGpPWpGaD
Suprofen—PTGS2—Disease—APC—ovarian cancer	5.68e-06	0.00041	CbGpPWpGaD
Suprofen—UGT1A1—Metabolism—PIK3CB—ovarian cancer	5.64e-06	0.000407	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—SLC2A1—ovarian cancer	5.54e-06	0.0004	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	5.42e-06	0.000391	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—CYP1B1—ovarian cancer	5.31e-06	0.000383	CbGpPWpGaD
Suprofen—PTGS1—Metabolism—PIK3CD—ovarian cancer	5.27e-06	0.00038	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—CAV1—ovarian cancer	5.23e-06	0.000377	CbGpPWpGaD
Suprofen—PTGS2—Disease—PIK3CD—ovarian cancer	5e-06	0.00036	CbGpPWpGaD
Suprofen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.99e-06	0.00036	CbGpPWpGaD
Suprofen—UGT1A1—Metabolism—PTEN—ovarian cancer	4.87e-06	0.000351	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—PIK3CG—ovarian cancer	4.76e-06	0.000343	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	4.71e-06	0.00034	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	4.69e-06	0.000338	CbGpPWpGaD
Suprofen—PTGS1—Metabolism—PIK3CB—ovarian cancer	4.59e-06	0.000331	CbGpPWpGaD
Suprofen—PTGS2—Disease—ERBB2—ovarian cancer	4.41e-06	0.000318	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—ABCB1—ovarian cancer	4.37e-06	0.000315	CbGpPWpGaD
Suprofen—PTGS2—Disease—MTOR—ovarian cancer	4.35e-06	0.000314	CbGpPWpGaD
Suprofen—PTGS2—Disease—PIK3CB—ovarian cancer	4.35e-06	0.000314	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—TYMS—ovarian cancer	4.29e-06	0.00031	CbGpPWpGaD
Suprofen—UGT2B7—Metabolism—PIK3CA—ovarian cancer	4.23e-06	0.000305	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—PIK3CD—ovarian cancer	4.18e-06	0.000302	CbGpPWpGaD
Suprofen—PTGS2—Disease—CDKN1B—ovarian cancer	4.09e-06	0.000295	CbGpPWpGaD
Suprofen—PTGS1—Metabolism—PTEN—ovarian cancer	3.97e-06	0.000286	CbGpPWpGaD
Suprofen—PTGS2—Disease—CTNNB1—ovarian cancer	3.86e-06	0.000279	CbGpPWpGaD
Suprofen—PTGS2—Disease—PTEN—ovarian cancer	3.76e-06	0.000271	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—PIK3CB—ovarian cancer	3.65e-06	0.000263	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—CAV1—ovarian cancer	3.46e-06	0.00025	CbGpPWpGaD
Suprofen—UGT2B7—Metabolism—AKT1—ovarian cancer	3.45e-06	0.000249	CbGpPWpGaD
Suprofen—UGT1A1—Metabolism—PIK3CA—ovarian cancer	3.44e-06	0.000248	CbGpPWpGaD
Suprofen—PTGS2—Disease—STAT3—ovarian cancer	3.37e-06	0.000243	CbGpPWpGaD
Suprofen—PTGS2—Disease—NRAS—ovarian cancer	3.36e-06	0.000242	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.31e-06	0.000238	CbGpPWpGaD
Suprofen—PTGS2—Disease—MAPK3—ovarian cancer	3.22e-06	0.000232	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—PIK3CG—ovarian cancer	3.15e-06	0.000227	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—PTEN—ovarian cancer	3.15e-06	0.000227	CbGpPWpGaD
Suprofen—PTGS2—Disease—MYC—ovarian cancer	3.13e-06	0.000226	CbGpPWpGaD
Suprofen—PTGS2—Disease—MAPK1—ovarian cancer	3.06e-06	0.000221	CbGpPWpGaD
Suprofen—PTGS2—Disease—EGFR—ovarian cancer	3.06e-06	0.000221	CbGpPWpGaD
Suprofen—PTGS2—Disease—KRAS—ovarian cancer	2.89e-06	0.000208	CbGpPWpGaD
Suprofen—UGT1A1—Metabolism—AKT1—ovarian cancer	2.81e-06	0.000202	CbGpPWpGaD
Suprofen—PTGS1—Metabolism—PIK3CA—ovarian cancer	2.8e-06	0.000202	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—PIK3CD—ovarian cancer	2.77e-06	0.0002	CbGpPWpGaD
Suprofen—PTGS2—Disease—PIK3CA—ovarian cancer	2.65e-06	0.000192	CbGpPWpGaD
Suprofen—PTGS2—Disease—HRAS—ovarian cancer	2.46e-06	0.000177	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—PIK3CB—ovarian cancer	2.42e-06	0.000174	CbGpPWpGaD
Suprofen—PTGS2—Disease—IL6—ovarian cancer	2.35e-06	0.00017	CbGpPWpGaD
Suprofen—PTGS1—Metabolism—AKT1—ovarian cancer	2.29e-06	0.000165	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—PIK3CA—ovarian cancer	2.22e-06	0.00016	CbGpPWpGaD
Suprofen—PTGS2—Disease—AKT1—ovarian cancer	2.17e-06	0.000156	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—PTEN—ovarian cancer	2.09e-06	0.000151	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—AKT1—ovarian cancer	1.82e-06	0.000131	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—PIK3CA—ovarian cancer	1.47e-06	0.000106	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—AKT1—ovarian cancer	1.2e-06	8.68e-05	CbGpPWpGaD
